2021
DOI: 10.1007/s10072-021-05570-y
|View full text |Cite
|
Sign up to set email alerts
|

“Glu/GABA-Gln” metabolic loop abnormalities in iminodipropionitrile (IDPN)-induced dyskinetic syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…This circulation is thought to prevent neuroexcitability caused by the production of too much Glu in the brain. GABA is a major inhibitory neurotransmitter in the central nervous system, which is directly synthesized by Glu through glutamate decarboxylase [ 32 ]. Meanwhile, the imbalance of Glu-GABA concentration has been considered as another hypothesis for the occurrence of migraine [ 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…This circulation is thought to prevent neuroexcitability caused by the production of too much Glu in the brain. GABA is a major inhibitory neurotransmitter in the central nervous system, which is directly synthesized by Glu through glutamate decarboxylase [ 32 ]. Meanwhile, the imbalance of Glu-GABA concentration has been considered as another hypothesis for the occurrence of migraine [ 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…As GABAA expression increases, the balance between GABA and Glu changes (Glykys et al 2019). Glu and GABA metabolism in the brain occurs primarily through the Glu/GABA-Gln metabolic loop (Hao et al 2021). A variety of neuropsychiatric disorders may be associated with this metabolic loop according to recent studies (Héja et al 2019).…”
Section: Discussionmentioning
confidence: 99%
“…The γ-GABA abnormality is present in many diseases and can be served as potential target. It was reported that abnormalities in Glu/GABA-Gln are present in rat dyskinetic syndrome, and the amino acid neurotransmitter imbalance was improved by “Tiapride,” which also increased the expression of GS and EAAT2 protein, decreased Glu levels, increased γ-GABA levels, and increased γ-GABA levels ( 89 ). Additionally, treatment with 10 mM γ-GABA considerably slowed down the loss of malate and titratable acidity and increased the levels of succinate and oxalate.…”
Section: Crosstalk Between Neuroendocrine Regulation and Tumor Cell M...mentioning
confidence: 99%
“…Notably, GABA administration drastically decreased ethylene production while also downregulating the expression of MdACS, MdACO, and MdERF. GABA therapy also boosted the accumulation of GABA and improved the function of the GABA shunt ( 89 ). The GABA A receptor agonist muscimol promotes gastric cancer cell growth by triggering mitogen-activated protein kinases (MAPK).…”
Section: Crosstalk Between Neuroendocrine Regulation and Tumor Cell M...mentioning
confidence: 99%